Sichuan Qinkang Jianzhijia Pharmaceutical Co., Ltd. announced that it will issue common shares for gross proceeds of CNY 20 million in a round of funding on August 25, 2023. The transaction will include participation from returning investor, Jianzhijia Pharmaceutical Chain Group Co., Ltd. The transaction has been approved at the 24th session of Jianzhijia Pharmaceutical Chain Group Co., Ltd. 5th directorate.